1. Home
  2. CPHI vs SBLX Comparison

CPHI vs SBLX Comparison

Compare CPHI & SBLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPHI
  • SBLX
  • Stock Information
  • Founded
  • CPHI N/A
  • SBLX 2017
  • Country
  • CPHI China
  • SBLX United States
  • Employees
  • CPHI N/A
  • SBLX N/A
  • Industry
  • CPHI Biotechnology: Pharmaceutical Preparations
  • SBLX Telecommunications Equipment
  • Sector
  • CPHI Health Care
  • SBLX Consumer Discretionary
  • Exchange
  • CPHI Nasdaq
  • SBLX Nasdaq
  • Market Cap
  • CPHI 4.7M
  • SBLX 4.0M
  • IPO Year
  • CPHI N/A
  • SBLX N/A
  • Fundamental
  • Price
  • CPHI $1.95
  • SBLX $5.78
  • Analyst Decision
  • CPHI
  • SBLX
  • Analyst Count
  • CPHI 0
  • SBLX 0
  • Target Price
  • CPHI N/A
  • SBLX N/A
  • AVG Volume (30 Days)
  • CPHI 26.1K
  • SBLX 738.4K
  • Earning Date
  • CPHI 11-12-2025
  • SBLX 11-13-2025
  • Dividend Yield
  • CPHI N/A
  • SBLX N/A
  • EPS Growth
  • CPHI N/A
  • SBLX N/A
  • EPS
  • CPHI N/A
  • SBLX N/A
  • Revenue
  • CPHI $4,396,201.00
  • SBLX $5,426.00
  • Revenue This Year
  • CPHI N/A
  • SBLX N/A
  • Revenue Next Year
  • CPHI N/A
  • SBLX N/A
  • P/E Ratio
  • CPHI N/A
  • SBLX N/A
  • Revenue Growth
  • CPHI N/A
  • SBLX N/A
  • 52 Week Low
  • CPHI $1.20
  • SBLX $4.20
  • 52 Week High
  • CPHI $3.35
  • SBLX $15.28
  • Technical
  • Relative Strength Index (RSI)
  • CPHI 60.72
  • SBLX 55.53
  • Support Level
  • CPHI $1.85
  • SBLX $4.85
  • Resistance Level
  • CPHI $1.97
  • SBLX $6.33
  • Average True Range (ATR)
  • CPHI 0.11
  • SBLX 0.45
  • MACD
  • CPHI -0.01
  • SBLX 0.06
  • Stochastic Oscillator
  • CPHI 78.00
  • SBLX 63.47

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

About SBLX StableX Technologies Inc. Common Stock

StableX Technologies Inc designs and manufactures compact, sustainable electric vehicles for closed campus mobility, low-speed urban and community transport, local on-demand and last-mile delivery, and government use. It operates as one reportable segment, focusing on the manufacturing and sales of environmentally-conscious, minimal-footprint EVs.

Share on Social Networks: